By Sheri Kasprzak
New York, Jan. 23 - Alltracel Pharmaceuticals plc said it intends to raise £1,105,200 from a stock placement.
The company is offering 10,047,273 shares at 11p each to expand its cardiovascular health trials program.
In particular, the company intends to use the proceeds for its sterol and omega-3 pre-clinical and clinical combination trials. The remainder of the proceeds will be used for working capital.
Based in London, Alltracel is a medical technology company focused on products for wound care, oral care and cardiovascular ailments.
| Issuer: | Alltracel Pharmaceuticals plc
|
| Issue: | Stock
|
| Amount: | £1,105,200
|
| Shares: | 10,047,273
|
| Price: | 11p
|
| Warrants: | No
|
| Pricing date: | Jan. 23
|
| Stock symbol: | London: AP
|
| Stock price: | 11.88p at close Jan. 23
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
